Inhibition assays using purified anti-CD151 immunoglobulin G from rat or rabbit in RBCs infected with P. falciparum trophozoite stages (FCR3 strain) or isolates from patients with severe malaria, showed statistically significant parasite inhibition in a dose-dependent manner (~30%). Here, CD151 is linked to malaria.